Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic pens are designed to deliver semaglutide through a stepwise dose escalation protocol, but understanding pen capacity and dose frequency helps you plan your weight management timeline. Each prefilled Ozempic pen holds enough medication for multiple weekly injections, though actual duration varies based on your personalized dose progression. PlexusDx provides an alternative approach with compounded semaglutide injections that start at $149 per month—without your dose may need to go up - your price won't increases.

How Many Doses Come in an Ozempic Pen

Standard Ozempic pens contain four pre-filled doses of semaglutide, with each dose typically representing 0.25 mg, 0.5 mg, 1 mg, or 2 mg depending on the pen strength. The pen is designed as a multi-dose device that delivers one subcutaneous injection weekly, meaning a single pen supplies four weeks of treatment at a consistent dose level. Ozempic pens are manufactured by Novo Nordisk and come in fixed-strength versions, so patients requiring dose escalation must switch between different pen strengths over time.

The four-dose capacity per pen reflects the standard GLP-1 receptor agonist titration schedule used in clinical practice, where patients start at a low dose and increase weekly or every few weeks. This structure allows prescribers to monitor tolerance and efficacy before patients advance to higher concentrations. However, the multi-step pen system means that each dose progression typically requires purchasing a new pen, which can complicate refill logistics and cost planning for ongoing therapy.

Typical Timeline for Using One Ozempic Pen

A single Ozempic pen typically lasts four weeks when following the standard once-weekly injection protocol, since each pen holds exactly four doses. If you remain at a single dose level during that month—for example, staying on the 0.5 mg dose—one pen covers your entire monthly treatment. However, most patients follow an escalation protocol where they increase their dose every one to four weeks, meaning a pen may last anywhere from one to four weeks depending on how quickly your healthcare provider advances your dose.

The Ozempic titration approach allows your provider to balance efficacy with side effect management, but it also means your pen supply won't align perfectly with calendar months. Some patients may finish a pen in two weeks during a dose increase phase, while others may use a pen for the full four weeks if they plateau at a maintenance dose. Tracking actual pen duration helps patients anticipate when they'll need refills and understand their total annual medication costs.

Dose Escalation Schedule and Multiple Pen Requirements

The standard Ozempic dose escalation follows a predictable pattern: patients begin at 0.25 mg weekly, advance to 0.5 mg after one week, then increase to 1 mg after another week, with optional escalation to 2 mg based on clinical response and tolerability. This four-week ramp-up means that if you're advancing through each dose level weekly, you'll need at least four separate pens during your first month of therapy—one strength per week. After the titration phase concludes, patients stabilize at a maintenance dose, typically 0.5 mg to 2.4 mg weekly, at which point pen usage becomes more predictable at four pens per month.

Because Ozempic pens come in fixed strengths, each dose change requires a new prescription and a new pen with a different concentration. This requirement increases the overall number of prescriptions, fills, and potentially out-of-pocket costs during the initial dose optimization period. In contrast, compounded semaglutide from licensed 503A pharmacies can be dosed more flexibly, allowing your provider to adjust the exact amount injected without purchasing multiple pen strengths.

How PlexusDx Compounded Semaglutide Differs from Ozempic Pens

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies, providing a cost-predictable alternative to branded Ozempic. Rather than requiring multiple pens at different strengths, PlexusDx patients receive a single vial of compounded semaglutide that allows their healthcare provider to prescribe precise, individualized doses that can increase without additional cost. PlexusDx compounded semaglutide starts at $149 per month flat—your dose may increase, but your price remains stable.

The compounded approach eliminates the logistical complexity of switching between Ozempic pen strengths during titration, reducing the total number of prescriptions and refills needed. PlexusDx serves all 50 states without requiring insurance, and treatment is HSA/FSA eligible for added affordability. Patients can also add the Precision Peptide Genetic Test ($99 add-on after the first month) to identify genetic variants that influence GLP-1 pathway response, helping their provider optimize their personalized semaglutide protocol from the start.

Storage and Expiration Timeline for Ozempic Pens

Unopened Ozempic pens remain stable for up to 30 months when stored at room temperature (59–86°F), giving patients flexibility in stocking doses before they begin treatment. Once a pen is opened and first used, it must be discarded after 28 days even if medication remains inside, regardless of whether you've used all four doses. This expiration policy means that patients who slow their dose escalation or pause therapy may waste unused doses if a pen expires before completion.

Proper storage is critical for maintaining semaglutide potency; pens should be kept away from direct heat and sunlight, and once opened, they must remain in a cool environment. If a pen is accidentally frozen or exposed to extreme temperatures, it should not be used. Understanding the 28-day post-opening window helps patients plan refill timing and avoid medication waste, especially during dose adjustment periods when usage patterns may be less predictable than at steady state.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long will one Ozempic pen last if I'm doing the standard dose escalation?

During the initial four-week titration phase, a standard Ozempic pen—containing four doses—may last only one week if you increase your dose weekly. Once you reach your maintenance dose and stay at the same strength, one pen will supply four weeks of weekly injections. Your healthcare provider can clarify your specific escalation timeline and expected pen duration.

Why do I need multiple Ozempic pens if one pen has four doses?

Ozempic pens come in fixed strengths (0.25 mg, 0.5 mg, 1 mg, or 2 mg), so advancing through the standard dose escalation protocol requires switching to a new pen at each dose level. Each new strength is a separate product, meaning you purchase multiple pens during titration rather than adjusting a single dose from one vial.

How does PlexusDx compounded semaglutide pricing work compared to Ozempic pens?

PlexusDx compounded semaglutide injections cost $149 per month flat, and that price stays the same no matter how high your dose goes. Ozempic pen costs vary by strength and insurance coverage, and you may purchase multiple pen strengths during dose escalation. PlexusDx eliminates flat per-compound pricing—your dose may increase, but your price won't.

What happens if I don't use all four doses in an Ozempic pen before 28 days pass?

Once an Ozempic pen is opened, it expires after 28 days and must be discarded even if medication remains inside. If your dose escalation is slower than expected or you pause treatment, you may waste unused doses. This is one reason why compounded semaglutide offers more flexibility—a provider can adjust your exact dose without forcing you to purchase an entire new pen strength.

Can the Precision Peptide Genetic Test help optimize my semaglutide dosing from the start?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 peptide pathways and identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide. This personalized genetic insight helps your PlexusDx provider design a more targeted dose escalation protocol tailored to your biology, potentially improving both efficacy and tolerability from day one.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves